ARCHIVES

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

This article is from The Cancer Letter archive.

Vol. 24 No. 46 | December 4, 1998

Download PDF Visit The Full Archive

Related Articles

NCI budget: a “Yes” to one thing means a “No” to something else, director says.

February 27, 2004

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

NCI-Approved CTEP Trials For the Month of November

November 30, 2012

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess”

September 11, 1981

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003